Biohaven pharmaceutical holding company limited reports earnings results for the third quarter ended september 30, 2019

Biohaven pharmaceutical holding company limited announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 90.456 million compared to usd 54.936 million a year ago. net loss was usd 106.167 million compared to usd 61.441 million a year ago. basic loss per share was usd 2.04 compared to usd 1.53 a year ago.
BHVN Ratings Summary
BHVN Quant Ranking